🚀 VC round data is live in beta, check it out!
Cementos Bio-Bio Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cementos Bio-Bio and similar public comparables like Konya Çimento, Titan USJE Skopje, Forterra, Eastern Province Cement and more.
Cementos Bio-Bio Overview
About Cementos Bio-Bio
Cementos Bio-Bio SA is a cement manufacturing company. The company manufactures and distributes construction materials.
Founded
1957
HQ
Employees
2.9K
Website
Sectors
Financials (FY)
EV
$589M
Cementos Bio-Bio Financials
Cementos Bio-Bio reported last fiscal year revenue of $398M and EBITDA of $55M.
In the same fiscal year, Cementos Bio-Bio generated $154M in gross profit, $55M in EBITDA, and $36M in net income.
Cementos Bio-Bio P&L
In the most recent fiscal year, Cementos Bio-Bio reported revenue of $398M and EBITDA of $55M.
Cementos Bio-Bio expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $398M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $154M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 39% | XXX | XXX | XXX |
| EBITDA | — | XXX | $55M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 12% | XXX | XXX | XXX |
| Net Profit | — | XXX | $36M | XXX | XXX | XXX |
| Net Margin | — | XXX | 9% | XXX | XXX | XXX |
| Net Debt | — | — | $52M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cementos Bio-Bio Stock Performance
Cementos Bio-Bio has current market cap of $491M, and enterprise value of $589M.
Market Cap Evolution
Cementos Bio-Bio's stock price is $1.86.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $589M | $491M | -0.8% | XXX | XXX | XXX | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCementos Bio-Bio Valuation Multiples
Cementos Bio-Bio trades at 1.5x EV/Revenue multiple, and 10.7x EV/EBITDA.
Cementos Bio-Bio Financial Valuation Multiples
As of April 2, 2026, Cementos Bio-Bio has market cap of $491M and EV of $589M.
Equity research analysts estimate Cementos Bio-Bio's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cementos Bio-Bio has a P/E ratio of 13.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $491M | XXX | $491M | XXX | XXX | XXX |
| EV (current) | $589M | XXX | $589M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 10.7x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 12.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.8x | XXX | XXX | XXX |
| P/E | — | XXX | 13.8x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 11.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cementos Bio-Bio Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cementos Bio-Bio Margins & Growth Rates
Cementos Bio-Bio's revenue in the last fiscal year grew by 3%.
Cementos Bio-Bio's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Cementos Bio-Bio Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (7%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 15% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cementos Bio-Bio Public Comps
See public comps and valuation multiples for other Building Materials comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Konya Çimento | XXX | XXX | XXX | XXX | XXX | XXX |
| Titan USJE Skopje | XXX | XXX | XXX | XXX | XXX | XXX |
| Forterra | XXX | XXX | XXX | XXX | XXX | XXX |
| Eastern Province Cement | XXX | XXX | XXX | XXX | XXX | XXX |
| PPC | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cementos Bio-Bio M&A Activity
Cementos Bio-Bio acquired XXX companies to date.
Last acquisition by Cementos Bio-Bio was on XXXXXXXX, XXXXX. Cementos Bio-Bio acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cementos Bio-Bio
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCementos Bio-Bio Investment Activity
Cementos Bio-Bio invested in XXX companies to date.
Cementos Bio-Bio made its latest investment on XXXXXXXX, XXXXX. Cementos Bio-Bio invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cementos Bio-Bio
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cementos Bio-Bio
| When was Cementos Bio-Bio founded? | Cementos Bio-Bio was founded in 1957. |
| Where is Cementos Bio-Bio headquartered? | Cementos Bio-Bio is headquartered in Chile. |
| How many employees does Cementos Bio-Bio have? | As of today, Cementos Bio-Bio has over 2K employees. |
| Is Cementos Bio-Bio publicly listed? | Yes, Cementos Bio-Bio is a public company listed on Bolsa de Santiago. |
| What is the stock symbol of Cementos Bio-Bio? | Cementos Bio-Bio trades under CEMENTOS ticker. |
| When did Cementos Bio-Bio go public? | Cementos Bio-Bio went public in 1982. |
| Who are competitors of Cementos Bio-Bio? | Cementos Bio-Bio main competitors are Konya Çimento, Titan USJE Skopje, Forterra, Eastern Province Cement. |
| What is the current market cap of Cementos Bio-Bio? | Cementos Bio-Bio's current market cap is $491M. |
| What is the current revenue of Cementos Bio-Bio? | Cementos Bio-Bio's last fiscal year revenue is $398M. |
| What is the current EV/Revenue multiple of Cementos Bio-Bio? | Current revenue multiple of Cementos Bio-Bio is 1.5x. |
| Is Cementos Bio-Bio profitable? | No, Cementos Bio-Bio is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.